

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | polyketide metabolic process (GO:0030638) | 9.58764342 |
| 2 | doxorubicin metabolic process (GO:0044598) | 9.58764342 |
| 3 | daunorubicin metabolic process (GO:0044597) | 9.58764342 |
| 4 | aminoglycoside antibiotic metabolic process (GO:0030647) | 6.01512365 |
| 5 | cytidine deamination (GO:0009972) | 4.84097809 |
| 6 | cytidine metabolic process (GO:0046087) | 4.84097809 |
| 7 | cytidine catabolic process (GO:0006216) | 4.84097809 |
| 8 | negative regulation of interleukin-12 production (GO:0032695) | 4.83314566 |
| 9 | phenol-containing compound catabolic process (GO:0019336) | 4.53586685 |
| 10 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.35015989 |
| 11 | regulation of response to osmotic stress (GO:0047484) | 4.23995023 |
| 12 | positive regulation of mast cell activation (GO:0033005) | 4.20939891 |
| 13 | phagocytosis, recognition (GO:0006910) | 4.19305486 |
| 14 | cellular extravasation (GO:0045123) | 4.14675697 |
| 15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.09495425 |
| 16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.09495425 |
| 17 | modulation by symbiont of host immune response (GO:0052553) | 4.09495425 |
| 18 | positive regulation by symbiont of host defense response (GO:0052509) | 4.09495425 |
| 19 | modulation by symbiont of host defense response (GO:0052031) | 4.09495425 |
| 20 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.09495425 |
| 21 | neutrophil activation (GO:0042119) | 4.03091651 |
| 22 | macrophage activation involved in immune response (GO:0002281) | 4.01559421 |
| 23 | granulocyte activation (GO:0036230) | 4.00723304 |
| 24 | microglial cell activation (GO:0001774) | 3.98281765 |
| 25 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.95455615 |
| 26 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.92690787 |
| 27 | maintenance of protein location in nucleus (GO:0051457) | 3.89924082 |
| 28 | detection of molecule of bacterial origin (GO:0032490) | 3.83391655 |
| 29 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.80931312 |
| 30 | regulation of mast cell activation (GO:0033003) | 3.67798429 |
| 31 | quinone metabolic process (GO:1901661) | 3.65320211 |
| 32 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.59944319 |
| 33 | detection of temperature stimulus (GO:0016048) | 3.58142916 |
| 34 | macrophage activation (GO:0042116) | 3.54481917 |
| 35 | neutrophil mediated immunity (GO:0002446) | 3.54309574 |
| 36 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.52133182 |
| 37 | regulation of cilium movement (GO:0003352) | 3.50244255 |
| 38 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.40751107 |
| 39 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.36951179 |
| 40 | positive regulation of mast cell degranulation (GO:0043306) | 3.36951179 |
| 41 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.35279160 |
| 42 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.34915061 |
| 43 | superoxide anion generation (GO:0042554) | 3.29840390 |
| 44 | neutrophil activation involved in immune response (GO:0002283) | 3.29804633 |
| 45 | myeloid cell activation involved in immune response (GO:0002275) | 3.28603372 |
| 46 | positive regulation of macrophage cytokine production (GO:0060907) | 3.24967751 |
| 47 | response to xenobiotic stimulus (GO:0009410) | 3.21621991 |
| 48 | response to dietary excess (GO:0002021) | 3.20510714 |
| 49 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.19764444 |
| 50 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.17572054 |
| 51 | GDP-mannose metabolic process (GO:0019673) | 3.16425314 |
| 52 | regulation of mast cell degranulation (GO:0043304) | 3.16167233 |
| 53 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.16119747 |
| 54 | negative regulation of interleukin-17 production (GO:0032700) | 3.14127166 |
| 55 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.12921116 |
| 56 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.12627810 |
| 57 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.11586179 |
| 58 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.05655712 |
| 59 | ATP synthesis coupled proton transport (GO:0015986) | 3.04519284 |
| 60 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.04519284 |
| 61 | electron transport chain (GO:0022900) | 3.03452449 |
| 62 | negative regulation of interleukin-1 production (GO:0032692) | 3.02304350 |
| 63 | somite rostral/caudal axis specification (GO:0032525) | 3.01524978 |
| 64 | positive regulation of TOR signaling (GO:0032008) | 3.00033602 |
| 65 | regulation of platelet activation (GO:0010543) | 2.97848923 |
| 66 | coenzyme catabolic process (GO:0009109) | 2.97236096 |
| 67 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.97130214 |
| 68 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.95175443 |
| 69 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.95046111 |
| 70 | respiratory electron transport chain (GO:0022904) | 2.94722508 |
| 71 | eosinophil chemotaxis (GO:0048245) | 2.94443124 |
| 72 | muscle organ morphogenesis (GO:0048644) | 2.91906171 |
| 73 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.91384141 |
| 74 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.90611189 |
| 75 | negative regulation of cell killing (GO:0031342) | 2.90611189 |
| 76 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.90553154 |
| 77 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.88951789 |
| 78 | myeloid leukocyte mediated immunity (GO:0002444) | 2.87798923 |
| 79 | T-helper 1 type immune response (GO:0042088) | 2.86553396 |
| 80 | phagocytosis, engulfment (GO:0006911) | 2.84781516 |
| 81 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.84711975 |
| 82 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.83378559 |
| 83 | regulation of interferon-alpha production (GO:0032647) | 2.79174912 |
| 84 | detection of other organism (GO:0098543) | 2.78638854 |
| 85 | response to host immune response (GO:0052572) | 2.78549987 |
| 86 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.78549987 |
| 87 | oligosaccharide catabolic process (GO:0009313) | 2.78367463 |
| 88 | detection of external biotic stimulus (GO:0098581) | 2.77807522 |
| 89 | cofactor catabolic process (GO:0051187) | 2.77738521 |
| 90 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.76644888 |
| 91 | arachidonic acid secretion (GO:0050482) | 2.75212445 |
| 92 | icosanoid secretion (GO:0032309) | 2.75212445 |
| 93 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.74118821 |
| 94 | neutrophil chemotaxis (GO:0030593) | 2.74068844 |
| 95 | negative regulation of mast cell activation (GO:0033004) | 2.72937186 |
| 96 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.72692454 |
| 97 | negative regulation of epidermis development (GO:0045683) | 2.72305652 |
| 98 | cellular response to ATP (GO:0071318) | 2.71781030 |
| 99 | regulation of mononuclear cell migration (GO:0071675) | 2.71033328 |
| 100 | regulation of interleukin-12 production (GO:0032655) | 2.71020633 |
| 101 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.70777994 |
| 102 | eosinophil migration (GO:0072677) | 2.70569091 |
| 103 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.69181560 |
| 104 | cullin deneddylation (GO:0010388) | 2.69098568 |
| 105 | nucleoside transmembrane transport (GO:1901642) | 2.68850759 |
| 106 | positive regulation of interleukin-6 production (GO:0032755) | 2.68375595 |
| 107 | germinal center formation (GO:0002467) | 2.68346980 |
| 108 | cellular response to arsenic-containing substance (GO:0071243) | 2.68328458 |
| 109 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.67995279 |
| 110 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.67806555 |
| 111 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.67311113 |
| 112 | neutrophil migration (GO:1990266) | 2.67197152 |
| 113 | phagosome maturation (GO:0090382) | 2.66224586 |
| 114 | tachykinin receptor signaling pathway (GO:0007217) | 2.66069291 |
| 115 | positive regulation of odontogenesis (GO:0042482) | 2.65385679 |
| 116 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.64716729 |
| 117 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.64716729 |
| 118 | proline transport (GO:0015824) | 2.64578451 |
| 119 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.64337905 |
| 120 | detection of biotic stimulus (GO:0009595) | 2.63618552 |
| 121 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.63497029 |
| 122 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.63460506 |
| 123 | cellular response to nicotine (GO:0071316) | 2.63319830 |
| 124 | interferon-gamma secretion (GO:0072643) | 2.62696543 |
| 125 | myeloid leukocyte activation (GO:0002274) | 2.62343572 |
| 126 | positive regulation of interferon-alpha production (GO:0032727) | 2.61601417 |
| 127 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.60770618 |
| 128 | positive regulation of interferon-beta production (GO:0032728) | 2.60563544 |
| 129 | leukocyte degranulation (GO:0043299) | 2.60434469 |
| 130 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.59245975 |
| 131 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.59150566 |
| 132 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.59150566 |
| 133 | negative regulation of lipid storage (GO:0010888) | 2.58977035 |
| 134 | regulation of interleukin-17 production (GO:0032660) | 2.58323055 |
| 135 | negative regulation of interleukin-6 production (GO:0032715) | 2.57954021 |
| 136 | activated T cell proliferation (GO:0050798) | 2.57196471 |
| 137 | respiratory burst (GO:0045730) | 2.56882987 |
| 138 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.56827883 |
| 139 | defense response to protozoan (GO:0042832) | 2.56379948 |
| 140 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.56282632 |
| 141 | response to water (GO:0009415) | 2.56176952 |
| 142 | response to protozoan (GO:0001562) | 2.55345380 |
| 143 | glycoside metabolic process (GO:0016137) | 2.52055778 |
| 144 | negative regulation of T cell mediated immunity (GO:0002710) | 2.51551209 |
| 145 | positive regulation of leukocyte degranulation (GO:0043302) | 2.49602542 |
| 146 | cytokine secretion (GO:0050663) | 2.49102599 |
| 147 | regulation of interleukin-6 production (GO:0032675) | 2.49024203 |
| 148 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.48821213 |
| 149 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.48517274 |
| 150 | nerve growth factor signaling pathway (GO:0038180) | 2.47830860 |
| 151 | Rap protein signal transduction (GO:0032486) | 2.47766279 |
| 152 | cyclooxygenase pathway (GO:0019371) | 2.47169379 |
| 153 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.47001583 |
| 154 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.46731241 |
| 155 | sequestering of actin monomers (GO:0042989) | 2.46728171 |
| 156 | regulation of regulatory T cell differentiation (GO:0045589) | 2.46515479 |
| 157 | positive regulation of heat generation (GO:0031652) | 2.46040185 |
| 158 | regulation of microtubule-based movement (GO:0060632) | 2.45581323 |
| 159 | positive regulation of tissue remodeling (GO:0034105) | 2.43947091 |
| 160 | monocyte chemotaxis (GO:0002548) | 2.43776730 |
| 161 | rRNA transcription (GO:0009303) | 2.42640345 |
| 162 | membrane raft organization (GO:0031579) | 2.41940088 |
| 163 | protein deneddylation (GO:0000338) | 2.41699069 |
| 164 | melanosome transport (GO:0032402) | 2.40215228 |
| 165 | establishment of melanosome localization (GO:0032401) | 2.37851675 |
| 166 | cofactor transport (GO:0051181) | 2.37622705 |
| 167 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.37512785 |
| 168 | response to peptidoglycan (GO:0032494) | 2.35488407 |
| 169 | regulation of monocyte chemotaxis (GO:0090025) | 2.34106016 |
| 170 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.33375338 |
| 171 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.33375338 |
| 172 | response to acidic pH (GO:0010447) | 2.30841557 |
| 173 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.30286040 |
| 174 | immunoglobulin mediated immune response (GO:0016064) | 2.29490721 |
| 175 | regulation of chemokine biosynthetic process (GO:0045073) | 2.28938320 |
| 176 | vasodilation (GO:0042311) | 2.28225386 |
| 177 | reactive oxygen species biosynthetic process (GO:1903409) | 2.28091760 |
| 178 | regulation of macrophage cytokine production (GO:0010935) | 2.27433952 |
| 179 | pigment granule transport (GO:0051904) | 2.26243607 |
| 180 | establishment of pigment granule localization (GO:0051905) | 2.24622562 |
| 181 | interferon-gamma production (GO:0032609) | 2.24484060 |
| 182 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.24211875 |
| 183 | NADH dehydrogenase complex assembly (GO:0010257) | 2.24211875 |
| 184 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.24211875 |
| 185 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.24032855 |
| 186 | creatine metabolic process (GO:0006600) | 2.22659314 |
| 187 | positive regulation of interleukin-17 production (GO:0032740) | 2.20409934 |
| 188 | negative regulation of B cell mediated immunity (GO:0002713) | 2.18555777 |
| 189 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.18555777 |
| 190 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 2.17224040 |
| 191 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.16995632 |
| 192 | protein complex biogenesis (GO:0070271) | 2.16281285 |
| 193 | positive regulation of digestive system process (GO:0060456) | 2.14168532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 9.68266096 |
| 2 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 4.91996952 |
| 3 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 4.91996952 |
| 4 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 4.91996952 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.58889564 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.73820312 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.68464171 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.68320471 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.39414991 |
| 10 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.30872904 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.24691724 |
| 12 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.13173087 |
| 13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.10870709 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.07366197 |
| 15 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.07340576 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.03954963 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.03284225 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.91579264 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.85735375 |
| 20 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.84724711 |
| 21 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.81849354 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.81214024 |
| 23 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.77923484 |
| 24 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.76088474 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.71990019 |
| 26 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.70487051 |
| 27 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.70322967 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.67019080 |
| 29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.62796715 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.62010608 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.61669052 |
| 32 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.58325004 |
| 33 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.57845155 |
| 34 | P300_19829295_ChIP-Seq_ESCs_Human | 1.56781332 |
| 35 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.53490167 |
| 36 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.48950092 |
| 37 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.48753606 |
| 38 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.48097535 |
| 39 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.47967068 |
| 40 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.42721061 |
| 41 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.42366856 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41640684 |
| 43 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.39702419 |
| 44 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.39619592 |
| 45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39578650 |
| 46 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.39045191 |
| 47 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.38916684 |
| 48 | EWS_26573619_Chip-Seq_HEK293_Human | 1.38655745 |
| 49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.36435809 |
| 50 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.35350837 |
| 51 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34578970 |
| 52 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.33165073 |
| 53 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.32491721 |
| 54 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.29774691 |
| 55 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.29073479 |
| 56 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.29002102 |
| 57 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28645260 |
| 58 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.28580446 |
| 59 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28220015 |
| 60 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.26530569 |
| 61 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25521025 |
| 62 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.24696691 |
| 63 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.22903131 |
| 64 | GATA3_26560356_Chip-Seq_TH2_Human | 1.22525986 |
| 65 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21495659 |
| 66 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.21380003 |
| 67 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.21173655 |
| 68 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.20075865 |
| 69 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19869909 |
| 70 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.19743594 |
| 71 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.18846950 |
| 72 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17746302 |
| 73 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17253027 |
| 74 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.16238234 |
| 75 | TP53_16413492_ChIP-PET_HCT116_Human | 1.16033295 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.15622557 |
| 77 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.14839023 |
| 78 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14716439 |
| 79 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.14716439 |
| 80 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.13952239 |
| 81 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.13464268 |
| 82 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.12628806 |
| 83 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.12405975 |
| 84 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.12188800 |
| 85 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11036226 |
| 86 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.10768856 |
| 87 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.10208419 |
| 88 | STAT3_23295773_ChIP-Seq_U87_Human | 1.10122351 |
| 89 | AR_25329375_ChIP-Seq_VCAP_Human | 1.09676323 |
| 90 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.09265422 |
| 91 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.09238947 |
| 92 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.09118640 |
| 93 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08388622 |
| 94 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.08322557 |
| 95 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.08044593 |
| 96 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.08031535 |
| 97 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.07369254 |
| 98 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.07057735 |
| 99 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06313322 |
| 100 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05702154 |
| 101 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05558566 |
| 102 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05440599 |
| 103 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05381511 |
| 104 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.04986994 |
| 105 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.04236117 |
| 106 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.03881652 |
| 107 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.03823903 |
| 108 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.03629192 |
| 109 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.03606797 |
| 110 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.02790624 |
| 111 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.02695813 |
| 112 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01556424 |
| 113 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.01336322 |
| 114 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.01296081 |
| 115 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.00636167 |
| 116 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99688782 |
| 117 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.99301657 |
| 118 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.99301657 |
| 119 | CJUN_26792858_Chip-Seq_BT549_Human | 0.99257112 |
| 120 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.99012517 |
| 121 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98648089 |
| 122 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98350571 |
| 123 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.98226677 |
| 124 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.98062653 |
| 125 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95890280 |
| 126 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95122006 |
| 127 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.94703352 |
| 128 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94585539 |
| 129 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.94452445 |
| 130 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94438147 |
| 131 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94395645 |
| 132 | FUS_26573619_Chip-Seq_HEK293_Human | 0.94373608 |
| 133 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.94249262 |
| 134 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.93144919 |
| 135 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92961104 |
| 136 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.92835914 |
| 137 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.92811299 |
| 138 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.92564273 |
| 139 | SPI1_23127762_ChIP-Seq_K562_Human | 0.92148321 |
| 140 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92037362 |
| 141 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.91856134 |
| 142 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.91450935 |
| 143 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90689107 |
| 144 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.90557089 |
| 145 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.90557089 |
| 146 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.90541854 |
| 147 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90427472 |
| 148 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.88985245 |
| 149 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.88728116 |
| 150 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.88620212 |
| 151 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.87589969 |
| 152 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.87084383 |
| 153 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.86604114 |
| 154 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.85434622 |
| 155 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.84314414 |
| 156 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.83999946 |
| 157 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.83372824 |
| 158 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.83074364 |
| 159 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83061744 |
| 160 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.82987198 |
| 161 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.82932608 |
| 162 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.82046438 |
| 163 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.81862487 |
| 164 | VDR_22108803_ChIP-Seq_LS180_Human | 0.81511186 |
| 165 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.80616923 |
| 166 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.80494979 |
| 167 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.79197967 |
| 168 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77810797 |
| 169 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.77485090 |
| 170 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.76530933 |
| 171 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.76472565 |
| 172 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.76427907 |
| 173 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.76380101 |
| 174 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76212231 |
| 175 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.75713481 |
| 176 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.75456981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004858_abnormal_nervous_system | 3.77821222 |
| 2 | MP0003011_delayed_dark_adaptation | 3.44211651 |
| 3 | MP0002254_reproductive_system_inflammat | 3.42999319 |
| 4 | MP0002332_abnormal_exercise_endurance | 2.92295413 |
| 5 | MP0005464_abnormal_platelet_physiology | 2.89404681 |
| 6 | MP0000343_altered_response_to | 2.85930877 |
| 7 | MP0000749_muscle_degeneration | 2.58709496 |
| 8 | MP0009764_decreased_sensitivity_to | 2.55057261 |
| 9 | MP0006082_CNS_inflammation | 2.53885160 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 2.20523044 |
| 11 | MP0001800_abnormal_humoral_immune | 2.20448566 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.20254889 |
| 13 | MP0006054_spinal_hemorrhage | 2.16838645 |
| 14 | MP0002723_abnormal_immune_serum | 2.14063567 |
| 15 | MP0000685_abnormal_immune_system | 2.12853402 |
| 16 | MP0000569_abnormal_digit_pigmentation | 2.05058935 |
| 17 | MP0003279_aneurysm | 1.93185865 |
| 18 | MP0004084_abnormal_cardiac_muscle | 1.91028258 |
| 19 | MP0003828_pulmonary_edema | 1.88344656 |
| 20 | MP0003195_calcinosis | 1.88342914 |
| 21 | MP0000920_abnormal_myelination | 1.83572113 |
| 22 | MP0002420_abnormal_adaptive_immunity | 1.82890619 |
| 23 | MP0008004_abnormal_stomach_pH | 1.82585910 |
| 24 | MP0001819_abnormal_immune_cell | 1.81363600 |
| 25 | MP0006035_abnormal_mitochondrial_morpho | 1.78776771 |
| 26 | MP0005257_abnormal_intraocular_pressure | 1.77827115 |
| 27 | MP0003122_maternal_imprinting | 1.77597475 |
| 28 | MP0003436_decreased_susceptibility_to | 1.74985386 |
| 29 | MP0009840_abnormal_foam_cell | 1.74800530 |
| 30 | MP0000750_abnormal_muscle_regeneration | 1.73301560 |
| 31 | MP0008438_abnormal_cutaneous_collagen | 1.70290344 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.68027157 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.67147032 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.65538065 |
| 35 | MP0003137_abnormal_impulse_conducting | 1.62415522 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.60485018 |
| 37 | MP0008775_abnormal_heart_ventricle | 1.60400685 |
| 38 | MP0004215_abnormal_myocardial_fiber | 1.59431981 |
| 39 | MP0002972_abnormal_cardiac_muscle | 1.57820663 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.56936650 |
| 41 | MP0009785_altered_susceptibility_to | 1.56922556 |
| 42 | MP0001905_abnormal_dopamine_level | 1.56256378 |
| 43 | MP0004036_abnormal_muscle_relaxation | 1.54979920 |
| 44 | MP0003950_abnormal_plasma_membrane | 1.49098372 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.48454794 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.48454794 |
| 47 | MP0005000_abnormal_immune_tolerance | 1.45782388 |
| 48 | MP0005623_abnormal_meninges_morphology | 1.45422258 |
| 49 | MP0002127_abnormal_cardiovascular_syste | 1.45066017 |
| 50 | MP0005330_cardiomyopathy | 1.44309979 |
| 51 | MP0000751_myopathy | 1.43343874 |
| 52 | MP0002138_abnormal_hepatobiliary_system | 1.42668258 |
| 53 | MP0003724_increased_susceptibility_to | 1.41911268 |
| 54 | MP0003075_altered_response_to | 1.40222522 |
| 55 | MP0003646_muscle_fatigue | 1.39948635 |
| 56 | MP0003183_abnormal_peptide_metabolism | 1.39063807 |
| 57 | MP0002295_abnormal_pulmonary_circulatio | 1.36168945 |
| 58 | MP0005394_taste/olfaction_phenotype | 1.35397998 |
| 59 | MP0005499_abnormal_olfactory_system | 1.35397998 |
| 60 | MP0005165_increased_susceptibility_to | 1.35330651 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.33113769 |
| 62 | MP0005164_abnormal_response_to | 1.32482391 |
| 63 | MP0003186_abnormal_redox_activity | 1.32387511 |
| 64 | MP0008469_abnormal_protein_level | 1.31915215 |
| 65 | MP0001835_abnormal_antigen_presentation | 1.31328450 |
| 66 | MP0004947_skin_inflammation | 1.30125562 |
| 67 | MP0010155_abnormal_intestine_physiology | 1.29976661 |
| 68 | MP0004510_myositis | 1.29531369 |
| 69 | MP0005075_abnormal_melanosome_morpholog | 1.29250623 |
| 70 | MP0004272_abnormal_basement_membrane | 1.27041724 |
| 71 | MP0003634_abnormal_glial_cell | 1.26626390 |
| 72 | MP0000716_abnormal_immune_system | 1.25674215 |
| 73 | MP0003690_abnormal_glial_cell | 1.23567204 |
| 74 | MP0002735_abnormal_chemical_nociception | 1.22001351 |
| 75 | MP0005647_abnormal_sex_gland | 1.19882466 |
| 76 | MP0001853_heart_inflammation | 1.19649567 |
| 77 | MP0004883_abnormal_blood_vessel | 1.18977665 |
| 78 | MP0005025_abnormal_response_to | 1.17916985 |
| 79 | MP0002733_abnormal_thermal_nociception | 1.16709796 |
| 80 | MP0002277_abnormal_respiratory_mucosa | 1.15520907 |
| 81 | MP0006036_abnormal_mitochondrial_physio | 1.15107893 |
| 82 | MP0006276_abnormal_autonomic_nervous | 1.14563825 |
| 83 | MP0000015_abnormal_ear_pigmentation | 1.14432157 |
| 84 | MP0000372_irregular_coat_pigmentation | 1.12654483 |
| 85 | MP0001663_abnormal_digestive_system | 1.12455437 |
| 86 | MP0000759_abnormal_skeletal_muscle | 1.12366849 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 1.11730380 |
| 88 | MP0004087_abnormal_muscle_fiber | 1.11078619 |
| 89 | MP0005174_abnormal_tail_pigmentation | 1.09993393 |
| 90 | MP0002419_abnormal_innate_immunity | 1.09945832 |
| 91 | MP0005310_abnormal_salivary_gland | 1.09558399 |
| 92 | MP0000689_abnormal_spleen_morphology | 1.07974153 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 1.07000714 |
| 94 | MP0002398_abnormal_bone_marrow | 1.06947318 |
| 95 | MP0005620_abnormal_muscle_contractility | 1.05622786 |
| 96 | MP0001970_abnormal_pain_threshold | 1.05479356 |
| 97 | MP0004270_analgesia | 1.05389066 |
| 98 | MP0009278_abnormal_bone_marrow | 1.02347630 |
| 99 | MP0003448_altered_tumor_morphology | 1.02170163 |
| 100 | MP0004043_abnormal_pH_regulation | 1.01944547 |
| 101 | MP0001727_abnormal_embryo_implantation | 1.01890896 |
| 102 | MP0003221_abnormal_cardiomyocyte_apopto | 1.00717337 |
| 103 | MP0002909_abnormal_adrenal_gland | 1.00221984 |
| 104 | MP0004264_abnormal_extraembryonic_tissu | 1.00088423 |
| 105 | MP0000767_abnormal_smooth_muscle | 1.00041388 |
| 106 | MP0004130_abnormal_muscle_cell | 0.99618892 |
| 107 | MP0004085_abnormal_heartbeat | 0.97803675 |
| 108 | MP0001968_abnormal_touch/_nociception | 0.96528601 |
| 109 | MP0001529_abnormal_vocalization | 0.95528293 |
| 110 | MP0001533_abnormal_skeleton_physiology | 0.95246234 |
| 111 | MP0005385_cardiovascular_system_phenoty | 0.95227688 |
| 112 | MP0001544_abnormal_cardiovascular_syste | 0.95227688 |
| 113 | MP0002736_abnormal_nociception_after | 0.94531434 |
| 114 | MP0002734_abnormal_mechanical_nocicepti | 0.94121333 |
| 115 | MP0001542_abnormal_bone_strength | 0.94045685 |
| 116 | MP0009333_abnormal_splenocyte_physiolog | 0.93542039 |
| 117 | MP0002106_abnormal_muscle_physiology | 0.93514714 |
| 118 | MP0005166_decreased_susceptibility_to | 0.91340790 |
| 119 | MP0002429_abnormal_blood_cell | 0.90894544 |
| 120 | MP0003172_abnormal_lysosome_physiology | 0.90561055 |
| 121 | MP0000604_amyloidosis | 0.88674983 |
| 122 | MP0010386_abnormal_urinary_bladder | 0.88325742 |
| 123 | MP0002405_respiratory_system_inflammati | 0.86592462 |
| 124 | MP0005390_skeleton_phenotype | 0.85831772 |
| 125 | MP0003329_amyloid_beta_deposits | 0.85492288 |
| 126 | MP0000230_abnormal_systemic_arterial | 0.84699435 |
| 127 | MP0002722_abnormal_immune_system | 0.84309486 |
| 128 | MP0005671_abnormal_response_to | 0.83926567 |
| 129 | MP0005167_abnormal_blood-brain_barrier | 0.82268932 |
| 130 | MP0003191_abnormal_cellular_cholesterol | 0.81440293 |
| 131 | MP0005369_muscle_phenotype | 0.80472646 |
| 132 | MP0002102_abnormal_ear_morphology | 0.80429023 |
| 133 | MP0003806_abnormal_nucleotide_metabolis | 0.79549630 |
| 134 | MP0009763_increased_sensitivity_to | 0.79490475 |
| 135 | MP0001790_abnormal_immune_system | 0.79158050 |
| 136 | MP0005387_immune_system_phenotype | 0.79158050 |
| 137 | MP0004484_altered_response_of | 0.78251226 |
| 138 | MP0003303_peritoneal_inflammation | 0.78110603 |
| 139 | MP0000249_abnormal_blood_vessel | 0.77073188 |
| 140 | MP0000371_diluted_coat_color | 0.76097664 |
| 141 | MP0005508_abnormal_skeleton_morphology | 0.75154792 |
| 142 | MP0006292_abnormal_olfactory_placode | 0.75090638 |
| 143 | MP0005266_abnormal_metabolism | 0.72873489 |
| 144 | MP0005197_abnormal_uvea_morphology | 0.72846791 |
| 145 | MP0001986_abnormal_taste_sensitivity | 0.71218961 |
| 146 | MP0008877_abnormal_DNA_methylation | 0.69922355 |
| 147 | MP0005084_abnormal_gallbladder_morpholo | 0.67711740 |
| 148 | MP0005248_abnormal_Harderian_gland | 0.66284086 |
| 149 | MP0001851_eye_inflammation | 0.66099682 |
| 150 | MP0003633_abnormal_nervous_system | 0.65200933 |
| 151 | MP0002653_abnormal_ependyma_morphology | 0.63297627 |
| 152 | MP0002132_abnormal_respiratory_system | 0.61574341 |
| 153 | MP0002693_abnormal_pancreas_physiology | 0.61390420 |
| 154 | MP0005595_abnormal_vascular_smooth | 0.60397139 |
| 155 | MP0004142_abnormal_muscle_tone | 0.60162084 |
| 156 | MP0002095_abnormal_skin_pigmentation | 0.59679695 |
| 157 | MP0008260_abnormal_autophagy | 0.58058874 |
| 158 | MP0000858_altered_metastatic_potential | 0.57767079 |
| 159 | MP0001324_abnormal_eye_pigmentation | 0.57100623 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 4.69736996 |
| 2 | Bilateral microphthalmos (HP:0007633) | 4.61343239 |
| 3 | Multiple enchondromatosis (HP:0005701) | 4.27058924 |
| 4 | Petechiae (HP:0000967) | 3.87310561 |
| 5 | Retrobulbar optic neuritis (HP:0100654) | 3.83387162 |
| 6 | Optic neuritis (HP:0100653) | 3.83387162 |
| 7 | Prolonged bleeding time (HP:0003010) | 3.62239072 |
| 8 | Increased serum pyruvate (HP:0003542) | 3.50587084 |
| 9 | Abnormality of glycolysis (HP:0004366) | 3.50587084 |
| 10 | Testicular atrophy (HP:0000029) | 3.48271389 |
| 11 | Sensory axonal neuropathy (HP:0003390) | 3.46070482 |
| 12 | Orchitis (HP:0100796) | 3.46005419 |
| 13 | Disinhibition (HP:0000734) | 3.45948926 |
| 14 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.40226102 |
| 15 | Ventricular tachycardia (HP:0004756) | 3.35784593 |
| 16 | Abnormality of glycolipid metabolism (HP:0010969) | 3.24708777 |
| 17 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.24708777 |
| 18 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.24708777 |
| 19 | Acute necrotizing encephalopathy (HP:0006965) | 3.23332025 |
| 20 | Myositis (HP:0100614) | 3.13556112 |
| 21 | Difficulty running (HP:0009046) | 2.98772988 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 2.95800794 |
| 23 | Mediastinal lymphadenopathy (HP:0100721) | 2.94400514 |
| 24 | Ragged-red muscle fibers (HP:0003200) | 2.93544745 |
| 25 | Increased connective tissue (HP:0009025) | 2.93532130 |
| 26 | Conjunctival telangiectasia (HP:0000524) | 2.89485881 |
| 27 | Autoimmune thrombocytopenia (HP:0001973) | 2.88905476 |
| 28 | Hematochezia (HP:0002573) | 2.88648623 |
| 29 | Axonal loss (HP:0003447) | 2.88428983 |
| 30 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.86728954 |
| 31 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.85215873 |
| 32 | Spontaneous hematomas (HP:0007420) | 2.85196620 |
| 33 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.83598017 |
| 34 | Gingival bleeding (HP:0000225) | 2.79527049 |
| 35 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.78422271 |
| 36 | Inappropriate behavior (HP:0000719) | 2.74622393 |
| 37 | Hypochromic microcytic anemia (HP:0004840) | 2.73277117 |
| 38 | Recurrent abscess formation (HP:0002722) | 2.72679765 |
| 39 | Epistaxis (HP:0000421) | 2.68754929 |
| 40 | 3-Methylglutaconic aciduria (HP:0003535) | 2.63367875 |
| 41 | Dysostosis multiplex (HP:0000943) | 2.62594992 |
| 42 | Mitochondrial inheritance (HP:0001427) | 2.61315363 |
| 43 | Progressive macrocephaly (HP:0004481) | 2.57974410 |
| 44 | Anomalous pulmonary venous return (HP:0010772) | 2.57168887 |
| 45 | Abolished electroretinogram (ERG) (HP:0000550) | 2.56555852 |
| 46 | EMG: myopathic abnormalities (HP:0003458) | 2.56055183 |
| 47 | Recurrent fungal infections (HP:0002841) | 2.53390072 |
| 48 | Eczematoid dermatitis (HP:0000976) | 2.51829083 |
| 49 | Keratoconjunctivitis sicca (HP:0001097) | 2.51817527 |
| 50 | Keratoconjunctivitis (HP:0001096) | 2.48215807 |
| 51 | Mutism (HP:0002300) | 2.46412599 |
| 52 | Partial duplication of thumb phalanx (HP:0009944) | 2.46383385 |
| 53 | Recurrent skin infections (HP:0001581) | 2.45322365 |
| 54 | Exercise-induced muscle cramps (HP:0003710) | 2.45146782 |
| 55 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.43677264 |
| 56 | Hypoplasia of the fovea (HP:0007750) | 2.43677264 |
| 57 | Abnormal pupillary function (HP:0007686) | 2.43354364 |
| 58 | Myotonia (HP:0002486) | 2.42670321 |
| 59 | Neuroendocrine neoplasm (HP:0100634) | 2.42301883 |
| 60 | Episodic fever (HP:0001954) | 2.41445791 |
| 61 | Pancreatic cysts (HP:0001737) | 2.41019922 |
| 62 | Abnormality of the pulmonary veins (HP:0011718) | 2.39650267 |
| 63 | Reduced antithrombin III activity (HP:0001976) | 2.38669958 |
| 64 | Increased cerebral lipofuscin (HP:0011813) | 2.38170471 |
| 65 | Sudden death (HP:0001699) | 2.36854853 |
| 66 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.36174721 |
| 67 | Polyneuropathy (HP:0001271) | 2.35753522 |
| 68 | Encephalitis (HP:0002383) | 2.34350589 |
| 69 | Rectovaginal fistula (HP:0000143) | 2.34007128 |
| 70 | Rectal fistula (HP:0100590) | 2.34007128 |
| 71 | Abnormal platelet volume (HP:0011876) | 2.33878858 |
| 72 | Muscle fiber splitting (HP:0003555) | 2.33317991 |
| 73 | Acute encephalopathy (HP:0006846) | 2.33235904 |
| 74 | Abnormality of T cell number (HP:0011839) | 2.32139573 |
| 75 | Increased CSF lactate (HP:0002490) | 2.31954154 |
| 76 | Fasciculations (HP:0002380) | 2.31751669 |
| 77 | Vaginal fistula (HP:0004320) | 2.31025203 |
| 78 | Leukocytosis (HP:0001974) | 2.30226034 |
| 79 | Increased variability in muscle fiber diameter (HP:0003557) | 2.29123298 |
| 80 | Congenital stationary night blindness (HP:0007642) | 2.28783433 |
| 81 | Atrial fibrillation (HP:0005110) | 2.28450089 |
| 82 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.27174393 |
| 83 | Peritonitis (HP:0002586) | 2.26941594 |
| 84 | Congenital sensorineural hearing impairment (HP:0008527) | 2.26481912 |
| 85 | Pulmonary infiltrates (HP:0002113) | 2.24540249 |
| 86 | Hyperventilation (HP:0002883) | 2.22890854 |
| 87 | Abnormal cartilage morphology (HP:0002763) | 2.22825213 |
| 88 | Abnormality of macrophages (HP:0004311) | 2.20694594 |
| 89 | Increased mean platelet volume (HP:0011877) | 2.20543134 |
| 90 | T lymphocytopenia (HP:0005403) | 2.19285572 |
| 91 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.18221001 |
| 92 | Primary atrial arrhythmia (HP:0001692) | 2.16432932 |
| 93 | Vasculitis (HP:0002633) | 2.15432975 |
| 94 | True hermaphroditism (HP:0010459) | 2.14073706 |
| 95 | Recurrent bacterial skin infections (HP:0005406) | 2.13819659 |
| 96 | Rib fusion (HP:0000902) | 2.13357004 |
| 97 | Obstructive lung disease (HP:0006536) | 2.13317736 |
| 98 | Chronic obstructive pulmonary disease (HP:0006510) | 2.13317736 |
| 99 | Supraventricular tachycardia (HP:0004755) | 2.11902967 |
| 100 | Recurrent cutaneous fungal infections (HP:0011370) | 2.11566917 |
| 101 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.11566917 |
| 102 | Decreased central vision (HP:0007663) | 2.11357279 |
| 103 | Partial duplication of the phalanx of hand (HP:0009999) | 2.10432854 |
| 104 | Hemoptysis (HP:0002105) | 2.10073592 |
| 105 | Amyloidosis (HP:0011034) | 2.09385542 |
| 106 | Renal Fanconi syndrome (HP:0001994) | 2.09368190 |
| 107 | Fused cervical vertebrae (HP:0002949) | 2.08223172 |
| 108 | Supraventricular arrhythmia (HP:0005115) | 2.08216693 |
| 109 | Hepatocellular necrosis (HP:0001404) | 2.07663922 |
| 110 | Neurofibrillary tangles (HP:0002185) | 2.06491638 |
| 111 | Progressive muscle weakness (HP:0003323) | 2.06385376 |
| 112 | Achilles tendon contracture (HP:0001771) | 2.04328317 |
| 113 | Pheochromocytoma (HP:0002666) | 2.01409094 |
| 114 | Hypokinesia (HP:0002375) | 2.01276420 |
| 115 | Hepatoblastoma (HP:0002884) | 2.00277576 |
| 116 | Pancreatic fibrosis (HP:0100732) | 1.99950077 |
| 117 | Stomach cancer (HP:0012126) | 1.98693153 |
| 118 | Trismus (HP:0000211) | 1.98600141 |
| 119 | Amblyopia (HP:0000646) | 1.97321412 |
| 120 | Loss of speech (HP:0002371) | 1.96615940 |
| 121 | Dyschromatopsia (HP:0007641) | 1.96239351 |
| 122 | Vertebral compression fractures (HP:0002953) | 1.95943846 |
| 123 | Failure to thrive in infancy (HP:0001531) | 1.95152136 |
| 124 | Diminished motivation (HP:0000745) | 1.94270170 |
| 125 | Paralysis (HP:0003470) | 1.94252461 |
| 126 | Nasolacrimal duct obstruction (HP:0000579) | 1.94246872 |
| 127 | Rapidly progressive (HP:0003678) | 1.94196976 |
| 128 | Arterial thrombosis (HP:0004420) | 1.94050819 |
| 129 | Steppage gait (HP:0003376) | 1.93202417 |
| 130 | Menorrhagia (HP:0000132) | 1.92425427 |
| 131 | Agitation (HP:0000713) | 1.90998222 |
| 132 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.90246556 |
| 133 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.90209964 |
| 134 | Exercise intolerance (HP:0003546) | 1.90184976 |
| 135 | Apathy (HP:0000741) | 1.89748596 |
| 136 | Bradycardia (HP:0001662) | 1.88747305 |
| 137 | Concave nail (HP:0001598) | 1.88568706 |
| 138 | Increased IgM level (HP:0003496) | 1.87800798 |
| 139 | Retinal dysplasia (HP:0007973) | 1.87508969 |
| 140 | Cerebral hemorrhage (HP:0001342) | 1.87356253 |
| 141 | Myocardial infarction (HP:0001658) | 1.87308248 |
| 142 | Respiratory failure (HP:0002878) | 1.87235910 |
| 143 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.86817326 |
| 144 | Mucosal telangiectasiae (HP:0100579) | 1.85956820 |
| 145 | Gastrointestinal infarctions (HP:0005244) | 1.85067158 |
| 146 | Abnormality of midbrain morphology (HP:0002418) | 1.84314937 |
| 147 | Molar tooth sign on MRI (HP:0002419) | 1.84314937 |
| 148 | Generalized hypotonia (HP:0001290) | 1.83075841 |
| 149 | Autoimmune hemolytic anemia (HP:0001890) | 1.82625409 |
| 150 | Purpura (HP:0000979) | 1.82624012 |
| 151 | Degeneration of anterior horn cells (HP:0002398) | 1.82487728 |
| 152 | Abnormality of the anterior horn cell (HP:0006802) | 1.82487728 |
| 153 | Chronic otitis media (HP:0000389) | 1.82315032 |
| 154 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.81847700 |
| 155 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.81831512 |
| 156 | Albinism (HP:0001022) | 1.81359511 |
| 157 | Horizontal nystagmus (HP:0000666) | 1.80796368 |
| 158 | Abnormality of the nasal mucosa (HP:0000433) | 1.80461411 |
| 159 | Gaze-evoked nystagmus (HP:0000640) | 1.80208858 |
| 160 | Difficulty walking (HP:0002355) | 1.79993951 |
| 161 | Hepatic necrosis (HP:0002605) | 1.79760200 |
| 162 | Muscle fibrillation (HP:0010546) | 1.79646938 |
| 163 | Metaphyseal irregularity (HP:0003025) | 1.78948704 |
| 164 | Absent/shortened dynein arms (HP:0200106) | 1.78727866 |
| 165 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.78727866 |
| 166 | Urticaria (HP:0001025) | 1.78692975 |
| 167 | Abnormality of secondary sexual hair (HP:0009888) | 1.78642676 |
| 168 | Abnormality of the axillary hair (HP:0100134) | 1.78642676 |
| 169 | Alveolar cell carcinoma (HP:0006519) | 1.77373745 |
| 170 | Anorexia (HP:0002039) | 1.77365197 |
| 171 | Abnormality of the prostate (HP:0008775) | 1.77231551 |
| 172 | Upper motor neuron abnormality (HP:0002127) | 1.76308724 |
| 173 | Genetic anticipation (HP:0003743) | 1.75874285 |
| 174 | Thick nail (HP:0001805) | 1.75235891 |
| 175 | Vertigo (HP:0002321) | 1.75160204 |
| 176 | Attenuation of retinal blood vessels (HP:0007843) | 1.73560859 |
| 177 | Gangrene (HP:0100758) | 1.73260342 |
| 178 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.73082820 |
| 179 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.73082820 |
| 180 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.73082820 |
| 181 | Eosinophilia (HP:0001880) | 1.72454351 |
| 182 | Abnormality of the salivary glands (HP:0010286) | 1.71767163 |
| 183 | Abnormality of the fovea (HP:0000493) | 1.71700706 |
| 184 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.70892635 |
| 185 | Type I transferrin isoform profile (HP:0003642) | 1.70520000 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GRK5 | 5.32308062 |
| 2 | ERN1 | 3.86610574 |
| 3 | FRK | 3.74401750 |
| 4 | GRK7 | 3.67928061 |
| 5 | ADRBK2 | 3.53673620 |
| 6 | ACVR1B | 3.52028855 |
| 7 | GRK6 | 3.03351538 |
| 8 | CSF1R | 2.49005232 |
| 9 | TAOK3 | 2.45349657 |
| 10 | TGFBR2 | 2.41650975 |
| 11 | NTRK1 | 2.40240253 |
| 12 | CDK12 | 2.26371263 |
| 13 | PIM2 | 2.22290424 |
| 14 | MATK | 2.20956259 |
| 15 | GRK1 | 2.14234215 |
| 16 | MOS | 2.06924913 |
| 17 | ARAF | 2.01622692 |
| 18 | MAP3K12 | 1.85762027 |
| 19 | MYLK | 1.85286984 |
| 20 | IRAK1 | 1.84167321 |
| 21 | TXK | 1.84086097 |
| 22 | RIPK4 | 1.71428054 |
| 23 | MAPK7 | 1.69522204 |
| 24 | STK39 | 1.69200736 |
| 25 | LIMK1 | 1.67121925 |
| 26 | BMPR1B | 1.60500262 |
| 27 | IRAK3 | 1.60302960 |
| 28 | MARK3 | 1.56053401 |
| 29 | TEC | 1.51685731 |
| 30 | MST4 | 1.49055002 |
| 31 | IKBKE | 1.48601783 |
| 32 | PRPF4B | 1.46688109 |
| 33 | ADRBK1 | 1.46348740 |
| 34 | WNK1 | 1.44847095 |
| 35 | NME2 | 1.42869818 |
| 36 | PRKG2 | 1.33705566 |
| 37 | BMPR2 | 1.33191997 |
| 38 | SGK2 | 1.33100897 |
| 39 | KIT | 1.29108701 |
| 40 | PIK3CG | 1.27623880 |
| 41 | MAP2K3 | 1.25040536 |
| 42 | BLK | 1.23346544 |
| 43 | CASK | 1.23161862 |
| 44 | TRIM28 | 1.22713726 |
| 45 | MAP3K3 | 1.21704902 |
| 46 | TYRO3 | 1.20481161 |
| 47 | MUSK | 1.19287367 |
| 48 | LMTK2 | 1.19249330 |
| 49 | PHKG2 | 1.18413809 |
| 50 | PHKG1 | 1.18413809 |
| 51 | PBK | 1.17308500 |
| 52 | MAP3K5 | 1.13490305 |
| 53 | IRAK2 | 1.13222430 |
| 54 | FES | 1.11928474 |
| 55 | SIK3 | 1.11853361 |
| 56 | TAOK2 | 1.11797626 |
| 57 | TESK2 | 1.09802434 |
| 58 | BTK | 1.08857490 |
| 59 | MAP4K1 | 1.07911169 |
| 60 | CHUK | 1.06293784 |
| 61 | PLK2 | 1.05288939 |
| 62 | NEK9 | 1.04299378 |
| 63 | MAPK12 | 1.00399225 |
| 64 | YES1 | 0.99451217 |
| 65 | TTN | 0.98796993 |
| 66 | ABL2 | 0.98421616 |
| 67 | TBK1 | 0.97970090 |
| 68 | CSK | 0.95303402 |
| 69 | SGK3 | 0.92680752 |
| 70 | TESK1 | 0.89190206 |
| 71 | KDR | 0.89137287 |
| 72 | WNK3 | 0.88295834 |
| 73 | TGFBR1 | 0.88012226 |
| 74 | TAOK1 | 0.86696605 |
| 75 | TLK1 | 0.86536703 |
| 76 | BRSK2 | 0.85141882 |
| 77 | CAMKK2 | 0.85103968 |
| 78 | STK24 | 0.83345705 |
| 79 | PAK4 | 0.82862399 |
| 80 | DAPK3 | 0.79664441 |
| 81 | JAK3 | 0.79019420 |
| 82 | SIK2 | 0.78857072 |
| 83 | STK10 | 0.78396146 |
| 84 | NUAK1 | 0.77801047 |
| 85 | DYRK3 | 0.77491857 |
| 86 | DAPK2 | 0.76892074 |
| 87 | DDR2 | 0.76421225 |
| 88 | KSR2 | 0.75199447 |
| 89 | MET | 0.75113013 |
| 90 | MAP2K4 | 0.72247302 |
| 91 | WNK4 | 0.69907268 |
| 92 | PTK2B | 0.66879628 |
| 93 | IRAK4 | 0.64064724 |
| 94 | EPHB1 | 0.63874776 |
| 95 | TRIB3 | 0.63406836 |
| 96 | JAK2 | 0.63053412 |
| 97 | MKNK2 | 0.60246341 |
| 98 | BCR | 0.60234264 |
| 99 | DYRK2 | 0.59622224 |
| 100 | IKBKB | 0.59329674 |
| 101 | CAMK4 | 0.58605854 |
| 102 | CAMK1D | 0.57815835 |
| 103 | ERBB3 | 0.57788259 |
| 104 | JAK1 | 0.57458136 |
| 105 | STK3 | 0.57453733 |
| 106 | ITK | 0.57358471 |
| 107 | PRKCD | 0.57132032 |
| 108 | FGR | 0.56527638 |
| 109 | HIPK2 | 0.55737100 |
| 110 | TNIK | 0.55602116 |
| 111 | MAP2K2 | 0.54648995 |
| 112 | SGK223 | 0.53979321 |
| 113 | SGK494 | 0.53979321 |
| 114 | IGF1R | 0.53623284 |
| 115 | MAP2K6 | 0.52283684 |
| 116 | PAK3 | 0.51568239 |
| 117 | MAPKAPK5 | 0.51144335 |
| 118 | CAMK1G | 0.50809701 |
| 119 | PDGFRB | 0.50525848 |
| 120 | MAP3K9 | 0.50364122 |
| 121 | MAP3K11 | 0.49998422 |
| 122 | PDK2 | 0.48868960 |
| 123 | ABL1 | 0.47692912 |
| 124 | MST1R | 0.46238333 |
| 125 | SYK | 0.45622420 |
| 126 | INSRR | 0.44267416 |
| 127 | PIM1 | 0.43114284 |
| 128 | MAP2K1 | 0.42680188 |
| 129 | MARK2 | 0.41939593 |
| 130 | BMX | 0.41915005 |
| 131 | CDK14 | 0.41891893 |
| 132 | EPHA3 | 0.41848633 |
| 133 | RPS6KA6 | 0.41330704 |
| 134 | MAPK13 | 0.41172514 |
| 135 | NME1 | 0.40959430 |
| 136 | PINK1 | 0.39969177 |
| 137 | OXSR1 | 0.39721222 |
| 138 | ILK | 0.38715719 |
| 139 | TRPM7 | 0.38526777 |
| 140 | TYK2 | 0.38465661 |
| 141 | LCK | 0.38315173 |
| 142 | PRKCE | 0.37506004 |
| 143 | ZAK | 0.37053068 |
| 144 | MAP3K13 | 0.35887635 |
| 145 | MAPK4 | 0.35107275 |
| 146 | TIE1 | 0.34033084 |
| 147 | DMPK | 0.33851862 |
| 148 | MAPKAPK3 | 0.32271086 |
| 149 | MAP3K14 | 0.32234938 |
| 150 | FYN | 0.32142937 |
| 151 | ROCK2 | 0.32029554 |
| 152 | MAP3K4 | 0.32003271 |
| 153 | PKN1 | 0.31976964 |
| 154 | ZAP70 | 0.31917564 |
| 155 | PRKD1 | 0.31547489 |
| 156 | OBSCN | 0.30871335 |
| 157 | CDC42BPA | 0.30401039 |
| 158 | PRKCQ | 0.29807784 |
| 159 | HCK | 0.28340672 |
| 160 | TNK2 | 0.27847093 |
| 161 | PDK4 | 0.27614785 |
| 162 | PDK3 | 0.27614785 |
| 163 | LYN | 0.27574515 |
| 164 | FGFR3 | 0.27432112 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.09267449 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.45425944 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.29454139 |
| 4 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.90065591 |
| 5 | Alzheimers disease_Homo sapiens_hsa05010 | 2.56509910 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.50036685 |
| 7 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.39936277 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.39139816 |
| 9 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.34147169 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.28538489 |
| 11 | Huntingtons disease_Homo sapiens_hsa05016 | 1.97773633 |
| 12 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.82103778 |
| 13 | Lysosome_Homo sapiens_hsa04142 | 1.81617498 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.77961038 |
| 15 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.74194366 |
| 16 | Phagosome_Homo sapiens_hsa04145 | 1.66809388 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.62148115 |
| 18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.61002780 |
| 19 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.60279503 |
| 20 | Protein export_Homo sapiens_hsa03060 | 1.54560452 |
| 21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.49240608 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.47532532 |
| 23 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.46861518 |
| 24 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.42541700 |
| 25 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.41944009 |
| 26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.40932003 |
| 27 | Proteasome_Homo sapiens_hsa03050 | 1.38832647 |
| 28 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.25723445 |
| 29 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.24695236 |
| 30 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.24587863 |
| 31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.23243104 |
| 32 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.20697020 |
| 33 | Galactose metabolism_Homo sapiens_hsa00052 | 1.20179924 |
| 34 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.19967580 |
| 35 | Measles_Homo sapiens_hsa05162 | 1.18814600 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.16547960 |
| 37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.14155667 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.13553488 |
| 39 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.13056440 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.12597215 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.10549113 |
| 42 | Salmonella infection_Homo sapiens_hsa05132 | 1.09205136 |
| 43 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.04650474 |
| 44 | Tuberculosis_Homo sapiens_hsa05152 | 1.03603362 |
| 45 | Sulfur relay system_Homo sapiens_hsa04122 | 1.03495071 |
| 46 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.03072349 |
| 47 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.02836014 |
| 48 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.01330363 |
| 49 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.01151263 |
| 50 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.96996911 |
| 51 | Pertussis_Homo sapiens_hsa05133 | 0.96916006 |
| 52 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.95473367 |
| 53 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.95404240 |
| 54 | Shigellosis_Homo sapiens_hsa05131 | 0.86430591 |
| 55 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.82739493 |
| 56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82250180 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.82080299 |
| 58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.78956769 |
| 59 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.78376975 |
| 60 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.78309583 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77002331 |
| 62 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.76812470 |
| 63 | Endocytosis_Homo sapiens_hsa04144 | 0.76772437 |
| 64 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.76303593 |
| 65 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.76193564 |
| 66 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.74900035 |
| 67 | Ribosome_Homo sapiens_hsa03010 | 0.74579655 |
| 68 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.74538052 |
| 69 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.73864460 |
| 70 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73391403 |
| 71 | Hepatitis B_Homo sapiens_hsa05161 | 0.71936868 |
| 72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.70930496 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69639972 |
| 74 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.68583169 |
| 75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67904392 |
| 76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67202636 |
| 77 | Legionellosis_Homo sapiens_hsa05134 | 0.66912085 |
| 78 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66524700 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66001815 |
| 80 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.64883820 |
| 81 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64361953 |
| 82 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63950563 |
| 83 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63591901 |
| 84 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.63327025 |
| 85 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.63198426 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.62970078 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.62791124 |
| 88 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62439088 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.61530309 |
| 90 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.61056599 |
| 91 | Apoptosis_Homo sapiens_hsa04210 | 0.60338133 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59094542 |
| 93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58581774 |
| 94 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57952388 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57895357 |
| 96 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.55690873 |
| 97 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.55344827 |
| 98 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.54821501 |
| 99 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.53233088 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | 0.52865330 |
| 101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52407915 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51893988 |
| 103 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.51826167 |
| 104 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.51818576 |
| 105 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.51190599 |
| 106 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50907877 |
| 107 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49432649 |
| 108 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.49125154 |
| 109 | Asthma_Homo sapiens_hsa05310 | 0.47808090 |
| 110 | Allograft rejection_Homo sapiens_hsa05330 | 0.46466312 |
| 111 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44039073 |
| 112 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42607706 |
| 113 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.42528439 |
| 114 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42059442 |
| 115 | Long-term depression_Homo sapiens_hsa04730 | 0.42038301 |
| 116 | Platelet activation_Homo sapiens_hsa04611 | 0.41235054 |
| 117 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.40406675 |
| 118 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39265347 |
| 119 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.38462204 |
| 120 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.38219566 |
| 121 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.38075601 |
| 122 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37002306 |
| 123 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.36778563 |
| 124 | Phototransduction_Homo sapiens_hsa04744 | 0.36405805 |
| 125 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.36329539 |
| 126 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.35905555 |
| 127 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.35640475 |
| 128 | Mineral absorption_Homo sapiens_hsa04978 | 0.34010945 |
| 129 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.33662049 |
| 130 | Olfactory transduction_Homo sapiens_hsa04740 | 0.33465808 |
| 131 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.32555945 |
| 132 | Focal adhesion_Homo sapiens_hsa04510 | 0.31538573 |
| 133 | Axon guidance_Homo sapiens_hsa04360 | 0.31501944 |
| 134 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.31210582 |
| 135 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.31141472 |
| 136 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30683571 |
| 137 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.29915161 |
| 138 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.29862338 |

